Fayyaz Minhas

Fayyaz Minhas

Auto-generated profile, based on publicly available information

Fayyaz Minhas

University of Warwick

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2010 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
MAMuhammad Arif
Muhammad Arif
IMIjaz A. Malagore
Ijaz A. Malagore
FAFayyaz A. Afsar
Fayyaz A. Afsar

24 September 2022 in Communications Medicine
Verified
Journal Article
Open access
PDF file
JPJohnathan Pocock
Johnathan Pocock
SGSimon Graham
Simon Graham
QVQuoc Dang Vu
Quoc Dang Vu
MJMostafa Jahanifar
Mostafa Jahanifar
SDSrijay Deshpande
Srijay Deshpande
SAShan E Ahmed
Shan E Ahmed
Background: Computational pathology has seen rapid growth in recent years, driven by advanced deep-learning algorithms. Due to the sheer size and complexity of multi-gigapixel whole-slide images, to the best of our knowledge, there is no open-source software library providing a generic end-to-end API for pathology image analysis using best practices. Most researchers have designed custom pipelines from the bottom up, restricting the development of advanced algorithms to specialist users. To help overcome this bottleneck, we present TIAToolbox, a Python toolbox designed to make computational pathology accessible to computational, biomedical, and clinical researchers. Methods: By creating modular and configurable components, we enable the implementation of computational pathology algorithms in a way that is easy to use, flexible and extensible. We consider common sub-tasks including reading whole slide image data, patch extraction, stain normalization and augmentation, model inference, and visualization. For each of these steps, we provide a user-friendly application programming interface for commonly used methods and models. Results: We demonstrate the use of the interface to construct a full computational pathology deep-learning pipeline. We show, with the help of examples, how state-of-the-art deep-learning algorithms can be reimplemented in a streamlined manner using our library with minimal effort. Conclusions: We provide a usable and adaptable library with efficient, cutting-edge, and unit-tested tools for data loading, pre-processing, model inference, post-processing, and visualization. This enables a range of users to easily build upon recent deep-learning developments in the computational pathology literature.

25 May 2022 in Medical Image Analysis
Verified
Journal Article
Open access
WLWenqi Lu
Wenqi Lu
MTMichael Toss
Michael Toss
MDMuhammad Dawood
Muhammad Dawood
Emad A RakhaEmad A Rakha
Emad A Rakha
NRNasir Rajpoot
Nasir Rajpoot
FMFayyaz Minhas
Fayyaz Minhas
Human epidermal growth factor receptor 2 (HER2) is an important prognostic and predictive factor which is overexpressed in 15-20% of breast cancer (BCa). The determination of its status is a key clinical decision making step for selection of treatment regimen and prognostication. HER2 status is evaluated using transcriptomics or immunohistochemistry (IHC) through in-situ hybridisation (ISH) which incurs additional costs and tissue burden and is prone to analytical variabilities in terms of manual observational biases in scoring. In this study, we propose a novel graph neural network (GNN) based model (SlideGraph+) to predict HER2 status directly from whole-slide images of routine Haematoxylin and Eosin (H&E) stained slides. The network was trained and tested on slides from The Cancer Genome Atlas (TCGA) in addition to two independent test datasets. We demonstrate that the proposed model outperforms the state-of-the-art methods with area under the ROC curve (AUC) values > 0.75 on TCGA and 0.80 on independent test sets. Our experiments show that the proposed approach can be utilised for case triaging as well as pre-ordering diagnostic tests in a diagnostic setting. It can also be used for other weakly supervised prediction problems in computational pathology. The SlideGraph+ code repository is available at https://github.com/wenqi006/SlideGraph along with an IPython notebook showing an end-to-end use case at https://github.com/TissueImageAnalytics/tiatoolbox/blob/develop/examples/full-pipelines/slide-graph.ipynb.

16 November 2013 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
FMFayyaz Ul Amir Afsar Minhas
Fayyaz Ul Amir Afsar Minhas
Brian GeissBrian Geiss
Brian Geiss
ABAsa Ben‐Hur
Asa Ben‐Hur

21 May 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SESimon Eitzinger
Simon Eitzinger
AAAmina Asif
Amina Asif
KWKyle E Watters
Kyle E Watters
AIAnthony T Iavarone
Anthony T Iavarone
GKGavin J Knott
Gavin J Knott
FMFayyaz Ul Amir Afsar Minhas
Fayyaz Ul Amir Afsar Minhas
The increasing use of CRISPR–Cas9 in medicine, agriculture, and synthetic biology has accelerated the drive to discover new CRISPR–Cas inhibitors as potential mechanisms of control for gene editing applications. Many anti-CRISPRs have been found that inhibit the CRISPR–Cas adaptive immune system. However, comparing all currently known anti-CRISPRs does not reveal a shared set of properties for facile bioinformatic identification of new anti-CRISPR families. Here, we describe AcRanker, a machine learning based method to aid direct identification of new potential anti-CRISPRs using only protein sequence information. Using a training set of known anti-CRISPRs, we built a model based on XGBoost ranking. We then applied AcRanker to predict candidate anti-CRISPRs from predicted prophage regions within self-targeting bacterial genomes and discovered two previously unknown anti-CRISPRs: AcrllA20 (ML1) and AcrIIA21 (ML8). We show that AcrIIA20 strongly inhibits Streptococcus iniae Cas9 (SinCas9) and weakly inhibits Streptococcus pyogenes Cas9 (SpyCas9). We also show that AcrIIA21 inhibits SpyCas9, Streptococcus aureus Cas9 (SauCas9) and SinCas9 with low potency. The addition of AcRanker to the anti-CRISPR discovery toolkit allows researchers to directly rank potential anti-CRISPR candidate genes for increased speed in testing and validation of new anti-CRISPRs. A web server implementation for AcRanker is available online at http://acranker.pythonanywhere.com/.

1 April 2019 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SGSadaf Gull
Sadaf Gull
NSNauman Shamim
Nauman Shamim
FMFayyaz Minhas
Fayyaz Minhas